O vs REGN · P/E 50, rev $5.27B vs P/E 14, rev $14.34B
Realty Income Corporation (O) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
O currently screens at market cap $56.48B and trailing P/E 49.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the O and REGN stock pages for the full models.
Not investment advice.